Why Hims & Hers Health, Inc. (HIMS) Stock Fell 12.9% on Jul 29, 2026
The clearest new catalyst: FTC lawsuit and privacy allegations.
Why did HIMS stock fall?
Hims & Hers Health fell 12.9% on July 29, 2026, driven by an FTC lawsuit alleging privacy violations, deceptive billing practices, and subscription-cancellation hurdles. The Federal Trade Commission, alongside attorneys general from Utah and California, sued the telehealth platform over claims it shared sensitive health information with third-party advertisers including Meta and Snap via tracking tools, and misled customers about free consultations by charging them before provider interaction. The company dismissed the allegations as baseless and said it would defend itself vigorously.
- FTC lawsuit and privacy allegations: The FTC, Utah, and California sued Hims & Hers alleging it shared sensitive health information with third-party advertisers like Meta and Snap using tracking tools such as the Meta Pixel, and misled customers about free consultations by automatically charging them before any real provider interaction.
- Subscription-cancellation complaints: The regulatory filing alleged the company intentionally made it difficult for consumers to cancel automatic subscription renewals.
- Peptide-compounding uncertainty: The decline was compounded by recent downward pressure from an FDA advisory panel's mixed decision regarding custom peptide compounding lists.
Initial detection
BestStocks first flagged HIMS intraday on Jul 29, 2026; this analysis was finalized after the close using the confirmed −12.9% session move and additional catalyst research.
Show the initial intraday note
Hims & Hers Health, Inc. (HIMS) moved -12.92% from $28.71 to $25.00 on 2026-07-29, reaching a new 30-day low on modestly elevated volume (1.4x the 5-day average). We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found.
What to watch next: HIMS earnings announcement on 2026-08-10 and the actual EPS result versus the -$0.07 consensus estimate.
Frequently asked questions
Why did Hims & Hers Health, Inc. (HIMS) stock fall on Jul 29, 2026?
Hims & Hers Health fell 12.9% on July 29, 2026, driven by an FTC lawsuit alleging privacy violations, deceptive billing practices, and subscription-cancellation hurdles. The Federal Trade Commission, alongside attorneys general from Utah and California, sued the telehealth platform over claims it shared sensitive health information with third-party advertisers including Meta and Snap via tracking tools, and misled customers about free consultations by charging them before provider interaction. The company dismissed the allegations as baseless and said it would defend itself vigorously.
How much did HIMS stock fall on Jul 29, 2026?
HIMS fell 12.9% during the Jul 29, 2026 trading session.
What were the main drivers behind HIMS's move?
FTC lawsuit and privacy allegations; Subscription-cancellation complaints; Peptide-compounding uncertainty.